These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 19945240

  • 1. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G.
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [Abstract] [Full Text] [Related]

  • 2. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L.
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [Abstract] [Full Text] [Related]

  • 3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 4. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
    Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ.
    Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
    [Abstract] [Full Text] [Related]

  • 5. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 7. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X, Huang X, Yan W, Wu L, Dai K.
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [Abstract] [Full Text] [Related]

  • 8. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
    Aukema TS, Olmos RA, Korse CM, Kroon BB, Wouters MW, Vogel WV, Bonfrer JM, Nieweg OE.
    Ann Surg Oncol; 2010 Jun; 17(6):1657-61. PubMed ID: 20151211
    [Abstract] [Full Text] [Related]

  • 9. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
    Bastiaannet E, Uyl-de Groot CA, Brouwers AH, van der Jagt EJ, Hoekstra OS, Oyen W, Verzijlbergen F, van Ooijen B, Thompson JF, Hoekstra HJ.
    Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
    [Abstract] [Full Text] [Related]

  • 11. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.
    J Nucl Med; 2008 Feb 01; 49(2):195-200. PubMed ID: 18199607
    [Abstract] [Full Text] [Related]

  • 13. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE.
    Invest Radiol; 2011 Sep 01; 46(9):548-55. PubMed ID: 21577131
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R.
    Ann Nucl Med; 2009 Jan 01; 23(1):49-57. PubMed ID: 19205838
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.
    Pediatr Blood Cancer; 2007 Dec 01; 49(7):901-5. PubMed ID: 17252575
    [Abstract] [Full Text] [Related]

  • 16. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S.
    Eur Urol; 2009 Aug 01; 56(2):339-45. PubMed ID: 19477581
    [Abstract] [Full Text] [Related]

  • 17. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
    Hahn S, Bauer S, Heusner TA, Ebeling P, Hamami ME, Stahl A, Forsting M, Bockisch A, Antoch G.
    Eur J Radiol; 2011 Dec 01; 80(3):670-4. PubMed ID: 20970938
    [Abstract] [Full Text] [Related]

  • 18. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct 01; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 19. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ.
    J Nucl Med; 2006 May 01; 47(5):755-62. PubMed ID: 16644744
    [Abstract] [Full Text] [Related]

  • 20. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP.
    Eur J Cancer; 2007 Feb 01; 43(3):557-64. PubMed ID: 17224266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.